Virtual Visits Market - Global Outlook and Forecast 2022-2027

297 pages

78 tables

159 charts

5 region

18 countries

40 company

4 segments

Purchase Options

$3500.00
$3995.00
$4995.00
$1500.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE GLOBAL VIRTUAL VISITS MARKET SIZE WAS VALUED AT USD 13.26 BILLION IN 2021 AND IS EXPECTED TO REACH USD 56.02 BILLION BY 2027, GROWING AT A CAGR OF 27.15%.

Virtual Visits Market Size, Share, & Trends Analysis Report by

  • Component: Service and Hardware
  • Application: General Consultation, Behavioral Health, Chronic Care Management, Urgent Care, and Others
  • Patient Group: Adults and Paediatric
  • Geography:: North America, APAC, Europe, Latin America, and MEA

Industry Analysis Report, Regional Outlook, Market Trends, Competitive Landscape, Share, Growth Potential & Forecast, 2022 – 2027

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

VIRTUAL VISITS MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2027)USD 56.02 Billion
Market Size (2021)USD 13.26 Billion
CAGR( 2022-2027)27.15%
Base Year2021
Forecast Year2022-2027
Market SegmentsComponent (Service and Hardware), Application (General Consultation, Behavioral Health, Chronic Care Management, Urgent Care, and Others), Patient Group(Adults and Pediatric)
Geographic AnalysisNorth America, APAC, Europe, Latin America, and MEA
Countries Covered
Interested in this Report?

Download a Sample!

MARKET INSIGHTS

The global virtual visits market was valued at USD 13.26 billion in 2021 and is expected to reach USD 56.02 billion by 2027, growing at a CAGR of 27.15%. In the virtual visit, a patient or medical professional uses a computer, smartphone, or tablet to obtain a diagnosis and send a prescription to their pharmacy. The visit is completed without leaving home or the workplace and amounts to far less than the cost of an emergency room or primary care office visit. Virtual visits are available to Health Action Council members and their employees from various vendors and providers. With the increasing telehealth utilization, there is also an increase in the adoption of virtual visit platforms. From 2017 to 2019, the virtual visit doubled for Health Action Council members.

Virtual care offers an easier, faster way to find and see a provider. Less than 2% of outpatient behavioral health and medical claims have been for virtual visits. According to CDC reports, virtual care has seen a 50% increase in March 2020 and continued to increase as lockdowns continued worldwide. According to studies, about 54% of respondents prefer to use virtual health as an option for consultation or diagnosis.

Throughout the COVID-19 pandemic, people have shifted to virtual care for medical and behavioral care because of convenience, ease of schedule, and have been found safe to avoid crowded waiting rooms. A recent report shows that about 76% of people are interested in using telehealth. Even after the pandemic ends, it is expected that about 83% of patients will use virtual care.

The following factors are likely to contribute to the virtual care market growth during the forecast period:

  • Rising reimbursements by insurers and the government during the COVID-19 pandemic
  • Rising adoption of patient care technology and growing digitalization
  • Increasing demand for personalized care in remote areas
  • Increasing Prevalence of chronic diseases and aging population

Advantages of Virtual Visits

  • Reduced waiting time
  • It saves the traveling time
  • Easy access to expertise and specialty physicians
  • Reduces overall cost of healthcare and treatment
  • Better disease management

The development of the telecommunication system has increased the scope of virtual care services immensely. With the introduction of virtual visit services, the growth of traditional medical diagnosis is growing at a moderate pace, especially in high-income countries where virtual visit has become a widespread practice for a consultation. The introduction of virtual visits has led to cost-effective treatment, adoption of home healthcare services, and low expenditure on infrastructure development. The virtual visit has revolutionized the healthcare industry as it reduces hospital visits, reduces patient wait time, and decreases the physical discomfort caused to patients. Further, globally, higher expenditure on healthcare IT by the major stakeholders in the healthcare industry is contributing to the global virtual visits market growth.

The rising incidences of chronic medical conditions such as diabetes and hypertension influence market growth. Virtual care is a valuable tool for continuous monitoring of chronic diseases and treatment. The adoption of virtual visit services is expected to rise with advancements in technology and high penetration of internet connectivity with more incredible speed & smart gadgets. Communication technologies (ICTs) and Modern information, such as computers, laptops, the Internet, and smartphones, are revolutionizing the communication among people that seek and exchange information and enriching their lives.

Artificial intelligence (AI) will add value and promote the virtual visit market growth. Artificial Intelligence paired with telehealth had been on the rise before the COVID-19, which created increased virtual visits capacity.

VENDORS' ACTIVITIES IN THE MARKET

The global virtual care market is highly dynamic and fragmented, with the presence of several international, regional, and local players. The key players in the market are AMD Global Telemedicine, American Well, Koninklijke Philips, and Teladoc Health.

  • Expansion activities (facility expansions and regional business) are helping players strengthen their market share and global distribution networks, thus allowing them to explore untapped opportunities.
  • Large-scale investments in the single-use bioprocessing probes and sensors market through varied conglomerates and investments firms
  • Forging partnerships and collaborations with well-established manufacturers cementing the footprints of the players
  • Active mergers and acquisitions play a vital role in the smooth functioning of the growth cycle.
  • The market is experiencing a surge in technological advancements in virtual care and the launch of new software and integrated hardware or devices or connected healthcare devices.
  • Vendors invest highly in integrating hardware or connected devices, software, and applications.
  • Key vendors operating in the market have demonstrated that they can provide reliable healthcare platforms to a large pool of patients at low cost or even zero cost per visit with the qualifying insurance plan in the US, depending on the type of visit.
  • Some key vendors offer services 24/7 in urgent care and provide on-demand video visits.
  • Many start-up companies are entering the market with the increased funding being received by the government and the private entities with innovative virtual visits platforms and solutions to gain traction among end-users
  • The key players make substantial R&D investments and develop innovative and technologically advanced products, thereby restricting small and medium-sized vendors from capturing higher market shares.

MARKET GROWTH ENABLERS

  • Rising reimbursements by insurers and the government during the COVID-19 pandemic
  • Rising adoption of patient care technology and growing digitalization
  • Increasing demand for personalized care in remote areas
  • Increasing Prevalence of chronic diseases and aging population

IMPACT OF COVID-19 PANDEMIC

Before the COVID-19 pandemic, the adoption of virtual visits remained low due to a lack of reimbursement, awareness, and internet connectivity. Also, there was a limited number of healthcare providers offering virtual visit services to medical professionals and patients.  Telehealth had been around for years before the COVID-19 crisis; there are many regulatory bodies and state parity laws that limited reimbursement by Medicare, Medicaid, and private insurers, curbed allowable sites of care, and placed licensure restrictions on who can provide telehealth services.

Virtual visit services have increased during the COVID-19 pandemic worldwide; the government is permitted to make consultations via virtual visit platforms by relaxing the regulations and increasing reimbursements.

With the surge in COVID-19 cases, the virtual care market jumped from 30% in 2020 to 33% in 2021, while satisfaction with asynchronous telehealth services leveraging pictures and videos grew from 41% to 54% in the same period. In 2020, 53% of US patients said they were more satisfied with live video than with previous in-person interactions.

MARKET SEGMENT ANALYSIS

The service segment is the fastest-growing segment by component, with the highest revenue of USD 10.35 billion in 2021, whereas hardware and software generated $2.91 billion. Several vendors offer a wide range of services in various specialties. The healthcare providers provide services giving both the options of a scheduled or on-demand visit. The services have widely been adopted in high-income countries and are also expected to gain momentum in low-and-middle-income countries. The hardware and software segment is expected to grow at an excellent pace in the forecast period, with a CAGR of 26.20%.

General consultation is the fastest-growing segment, with a CAGR of 25.90%. There were full restrictions worldwide to go outside, and fear of getting COVID-19 infection within hospitals led to increased virtual visits worldwide. The chronic care management market is expected to grow due to the increasing prevalence of chronic diseases and the increasing elderly population. Chronic care management services also give cost-benefit as most of the service fee is cut to as low as $0, depending on the patient's insurance plan, thus saving the overall visit cost. Also, initiatives are increasing support for chronic care management virtual visit services.

Adults are the fastest-growing patient group because of their increasing use of virtual visits. The high population and increasing chronic diseases among adults, especially in the geriatric population, have increased the demand for virtual visits. The use of virtual visit platforms and services is very high among adults from high-income countries with good infrastructure, good internet access, and awareness. The pediatric group is expected to grow at a CAGR of 23.85% during the forecast period.

GEOGRAPHICAL ANALYSIS

North America and Europe have the highest adoption rate of telehealth services due to high internet connectivity, increasing reimbursements, and full insurance coverage. In addition, North America dominates the critical vendor's presence. APAC, Latin America, and the Middle East & Africa region witnessed an increase in the adoption during a pandemic. However, limited reimbursement coverage, data security, privacy concern, lack of infrastructure, and a lack of consumer awareness of telehealth services are hindering the growth of the virtual visits market in these regions.

Frequently Asked Questions

How big is the global Virtual Visits market?

The global virtual visits market size was valued at $13.26 billion in 2021 and is expected to reach $56.02 billion by 2027, growing at a CAGR of 27.15%.

What is the growth rate of the global virtual visits market?

The global virtual visits market is growing at a CAGR of 27.15% from 2022 to 2027.

Who are the leading players in the global virtual visits market?

The key players in the market are AMD Global Telemedicine, American Well, Koninklijke Philips, and Teladoc Health

Which region has the highest number of virtual visits service providers?

North America dominates the virtual care market with the presence of critical vendors.

What is the growth rate of the hardware and software segment of the global virtual visits market?

The hardware and software segment is expected to grow at an excellent pace in the forecast period, with a CAGR of 26.20%.

The global virtual visits market size was valued at $13.26 billion in 2021 and is expected to reach $56.02 billion by 2027, growing at a CAGR of 27.15%.

Base Year: 2021

Forecast Year: 2022–2027

The study considers the present scenario of the virtual visits market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Major Vendors

  • AMD Global Telemedicine
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • American Well
  • Koninklijke Philips
  • Teladoc Health

Other Prominent Vendors

  • Banner Health
    • Business Overview
    • Product Offerings
  • Beato
  • Blue Sky MD
  • Careclix
  • Cerner
  • CHI Health
  • Chiron Health
  • CVS Health
  • Dialogue
  • Doctor On Demand
  • Doxy(.) ME
  • Eagle Telemedicine
  • Edgemed Healthcare
  • eVisit
  • HealthTap
  • Health at Hand
  • HealthHero
  • Instapract
  • MDLive
  • MediBuddy
  • MFine
  • NeuroSynaptic Communications
  • Nextcare
  • Optum
  • Plushcare
  • Piedmont Healthcare
  • Practo
  • RO
  • Reecuro Health
  • SteadyMD
  • SOC Telemed
  • TRUDOC Healthcare
  • Vidyo
  • VSee
  • Walmart Health Virtual Care
  • Zipnosis

Segmentation by Component:

  • Service
  • Hardware

Segmentation by Application:

  • General Consultation
  • Behavioral Health
  • Chronic Care Management
  • Urgent Care
  • Others

Segmentation by Patient Group

  • Adults
  • Paediatric

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • Australia
    • South Korea
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • The Middle East and Africa
    • Turkey
    • UAE
    • South Africa

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL VIRTUAL VISITS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 BENEFITS OF VIRTUAL VISITS

EXHIBIT 4 US ADULTS WHO OWN GADGETS 2018 (% SHARE)

EXHIBIT 5 RISE IN PATIENT-CARE TECHNOLOGY

EXHIBIT 6 GLOBAL VIRTUAL VISITS MARKET OVERVIEW

EXHIBIT 7 VIRTUAL VISITS MARKET GROWTH FACTORS

EXHIBIT 8 VIRTUAL VISITS MARKET SEGMENT BY GEOGRAPHY

EXHIBIT 9 IMPACT OF EMERGING SMART INTEGRATED DEVICES

EXHIBIT 10 IMPACT OF INCREASING GROWTH OF VIRTUAL VISITS ACTIVITIES

EXHIBIT 11 TOTAL ANNUAL REVENUES OF TELEHEALTH PLAYERS ($ BILLION)

EXHIBIT 12 TOTAL VENTURE FUNDING FOR DIGITAL HEALTH COMPANIES 2017-2020 ($ BILLION)

EXHIBIT 13 IMPACT OF INCREASING STRATEGIC PARTNERSHIPS & MERGERS/ACQUISITIONS

EXHIBIT 14 IMPACT OF HIGHER REIMBURSEMENTS BY INSURERS AND GOVERNMENTS FOR VIRTUAL VISITS

EXHIBIT 15 VIRTUAL VISITS DELIVERY BY PAYERS

EXHIBIT 16 IMPACT OF LARGER TARGET POOL OF PATIENTS REQUIRING VIRTUAL VISITS

EXHIBIT 17 BENEFITS OF VIRTUAL VISITS FOR BETTER CHRONIC DISEASE MANAGEMENT

EXHIBIT 18 IMPACT OF RISE OF VIRTUAL HOSPITALS

EXHIBIT 19 ARCHITECTURE OF VIRTUAL HOSPITAL SOLUTION

EXHIBIT 20 IMPACT OF LACK OF ACCESS TO FIXED INTERNET SERVICE

EXHIBIT 21 GLOBAL INTERNET ACCESS 2019

EXHIBIT 22 IMPACT OF LEGAL BARRIERS & LACK OF STANDARD REGULATIONS FOR VIRTUAL VISITS

EXHIBIT 23 IMPACT OF DATA SECURITY AND PRIVACY RISKS

EXHIBIT 24 US POPULATION OPINION ON ACCESS TO FOLLOWING TYPES OF INFORMATION 2019 (% SHARE)

EXHIBIT 25 GLOBAL VIRTUAL VISITS MARKET 2021–2027 ($ BILLION)

EXHIBIT 26 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT 2021 & 2027 (%)

EXHIBIT 27 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION 2021 & 2027 (%)

EXHIBIT 28 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP 2021 & 2027 (%)

EXHIBIT 29 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY 2021 & 2027 (%)

EXHIBIT 30 FIVE FORCES ANALYSIS 2021

EXHIBIT 31 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 32 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT

EXHIBIT 33 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT: OVERVIEW

EXHIBIT 34 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT: GROWTH POTENTIAL

EXHIBIT 35 GLOBAL VIRTUAL VISITS BY COMPONENT – INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 36 GLOBAL VIRTUAL VISITS BY COMPONENT – ABSOLUTE GROWTH (%)

EXHIBIT 37 GLOBAL VIRTUAL VISITS MARKET BY SERVICE – INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 38 GLOBAL VIRTUAL VISITS MARKET BY SERVICE 2021–2027 ($ BILLION)

EXHIBIT 39 SERVICE INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 40 GLOBAL VIRTUAL VISITS MARKET BY HARDWARE & SOFTWARE – INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 41 GLOBAL VIRTUAL VISITS MARKET BY HARDWARE & SOFTWARE 2021–2027 ($ BILLION)

EXHIBIT 42 HARDWARE & SOFTWARE INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 43 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 44 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION

EXHIBIT 45 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION: OVERVIEW

EXHIBIT 46 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION: GROWTH POTENTIAL

EXHIBIT 47 GLOBAL VIRTUAL VISITS BY APPLICATION – INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 48 GLOBAL VIRTUAL VISITS BY APPLICATION – ABSOLUTE GROWTH (%)

EXHIBIT 49 SHORT-TERM, LONG-TERM, AND PREVENTIVE CARE DURING A TOTAL OF 1.49 MILLION VIRTUAL VISITS ACROSS ALL SPECIALTIES IN THE US FROM 2018-2020 (%)

EXHIBIT 50 PERCENTAGE OF ADULTS 65 AND OLDER IN SELECTED COUNTRIES WHO RECEIVED FLU SHOTS (2019)

EXHIBIT 51 GLOBAL VIRTUAL VISITS MARKET BY GENERAL CONSULTATION – INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL VIRTUAL VISITS MARKET BY GENERAL CONSULTATION 2021–2027 ($ BILLION)

EXHIBIT 53 GENERAL CONSULTATION INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 54 GLOBAL VIRTUAL VISITS MARKET BY BEHAVIORAL HEALTH – INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL VIRTUAL VISITS MARKET BY BEHAVIORAL HEALTH 2021–2027 ($ BILLION)

EXHIBIT 56 BEHAVIORAL HEALTH INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 57 AVERAGE WEEKLY VISIT RATES/1,000 PATIENTS BY CHRONIC CONDITIONS BEFORE (JANUARY 2018- MARCH 2020) AND DURING (MARCH 2020- JANUARY 2021) PANDEMIC (%)

EXHIBIT 58 GLOBAL VIRTUAL VISITS MARKET BY CHRONIC CARE MANAGEMENT – INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 59 GLOBAL VIRTUAL VISITS MARKET BY CHRONIC CARE MANAGEMENT 2021–2027 ($ BILLION)

EXHIBIT 60 CHRONIC CARE MANAGEMENT INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 61 GLOBAL VIRTUAL VISITS MARKET BY URGENT CARE 2021–2027 ($ BILLION)

EXHIBIT 62 GLOBAL VIRTUAL VISITS MARKET BY URGENT CARE – INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 63 URGENT CARE INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 64 MOST COMMON SKIN DISEASES FOUND IN A STUDY OF 2,701 INDIVIDUALS 2019 (%)

EXHIBIT 65 GLOBAL VIRTUAL VISITS MARKET BY OTHERS 2021–2027 ($ BILLION)

EXHIBIT 66 GLOBAL VIRTUAL VISITS MARKET BY OTHERS – INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 67 OTHERS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 68 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027

EXHIBIT 69 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP

EXHIBIT 70 PERCENTAGES OF VIRTUAL VISITS BY AGE-GROUP WITH CANCER

EXHIBIT 71 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP: OVERVIEW

EXHIBIT 72 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP: GROWTH POTENTIAL

EXHIBIT 73 GLOBAL VIRTUAL VISITS BY PATIENT GROUP – INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 74 GLOBAL VIRTUAL VISITS BY PATIENT GROUP – ABSOLUTE GROWTH (%)

EXHIBIT 75 ADULTS CONSULTING REGULAR DERMATOLOGIST (%)

EXHIBIT 76 PERCENTAGE OF ADULTS (50-80 YEARS) WHO VISITED VIRTUAL VISITS BY SERVICE (2020)

EXHIBIT 77 GLOBAL VIRTUAL VISITS MARKET BY ADULTS 2021–2027 ($ BILLION)

EXHIBIT 78 GLOBAL VIRTUAL VISITS MARKET BY ADULTS– INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 79 ADULTS INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 80 PEDIATRIC PATIENTS SEEN BY VIDEO VISITS 2020

EXHIBIT 81 GLOBAL VIRTUAL VISIT MARKET BY PEDIATRIC 2021–2027 ($ BILLION)

EXHIBIT 82 GLOBAL VIRTUAL VISITS MARKET BY PEDIATRIC– INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 83 PEDIATRIC INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 84 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 85 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY

EXHIBIT 86 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY – INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 87 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY – ABSOLUTE GROWTH (%)

EXHIBIT 88 NORTH AMERICAN VIRTUAL VISITS MARKET – KEY COUNTRIES – 2021 ($ BILLION)

EXHIBIT 89 VIRTUAL VISITS MARKET IN NORTH AMERICA 2021–2027 ($ BILLION)

EXHIBIT 90 NORTH AMERICA VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 91 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 92 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 93 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027

EXHIBIT 94 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027 ($ BILLION)

EXHIBIT 95 TELEHEALTH AMBULATORY CONTACTS FOR CONTINUOUSLY ENROLLED INSURED STUDY COHORT FOR MARCH TO JUNE 2020

EXHIBIT 96 VIRTUAL VISITS MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 97 VIRTUAL VISITS MARKET IN CANADA 2021–2027 ($ BILLION)

EXHIBIT 98 EUROPE VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH ($ BILLION)

EXHIBIT 99 DISTRIBUTION OF VIDEO CONSULTATION SERVICES BY HEALTHCARE ORGANIZATIONS IN EUROPE IN 2020 BY ADOPTION STAGE

EXHIBIT 100 EUROPE VIRTUAL VISITS MARKET – KEY COUNTRIES – 2021 ($ BILLION)

EXHIBIT 101 VIRTUAL VISITS MARKET IN EUROPE 2021–2027 ($ BILLION)

EXHIBIT 102 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 103 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 104 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027

EXHIBIT 105 INCREMENTAL GROWTH IN EUROPE 2021 & 2027 ($ BILLION)

EXHIBIT 106 NARROWING OF GENERATION GAP IN USING DIGITAL TECHNOLOGIES AMONG ADULTS IN UK

EXHIBIT 107 VIRTUAL VISITS MARKET IN UK 2021–2027 ($ BILLION)

EXHIBIT 108 VIRTUAL VISITS MARKET IN FRANCE 2021–2027 ($ BILLION)

EXHIBIT 109 VIRTUAL VISITS MARKET IN GERMANY 2021–2027 ($ BILLION)

EXHIBIT 110 SHARE OF RESPONSES OF TYPE OF TELEHEALTH SOLUTIONS/SERVICES PROVIDERS PLAN TO OFFER IN THE UPCOMING YEARS (2020 SURVEY)

EXHIBIT 111 VIRTUAL VISITS MARKET IN ITALY 2021–2027 ($ BILLION)

EXHIBIT 112 VIRTUAL VISITS MARKET IN SPAIN 2021–2027 ($ BILLION)

EXHIBIT 113 APAC VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH ($ BILLION)

EXHIBIT 114 APAC VIRTUAL VISITS MARKET – KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 115 VIRTUAL VISITS MARKET IN APAC 2021–2027 ($ BILLION)

EXHIBIT 116 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 117 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 118 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027

EXHIBIT 119 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 120 VIRTUAL VISITS MARKET IN JAPAN 2021–2027 ($ BILLION)

EXHIBIT 121 VIRTUAL VISITS MARKET IN CHINA 2021–2027 ($ BILLION)

EXHIBIT 122 VIRTUAL VISITS MARKET IN AUSTRALIA 2021–2027 ($ BILLION)

EXHIBIT 123 VIRTUAL VISITS MARKET IN SOUTH KOREA 2021–2027 ($ BILLION)

EXHIBIT 124 TELECONSULTATIONS IN DIFFERENT SPECIALTY IN 2020 (%)

EXHIBIT 125 VIRTUAL VISITS MARKET IN INDIA 2021–2027 ($ BILLION)

EXHIBIT 126 LATIN AMERICA VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 127 LATIN AMERICA VIRTUAL VISITS MARKET – KEY COUNTRIES – 2021 ($ BILLION)

EXHIBIT 128 VIRTUAL VISITS MARKET IN LATIN AMERICA 2021–2027 ($ BILLION)

EXHIBIT 129 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 130 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 131 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027

EXHIBIT 132 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 133 BRAZIL: INTERNET USER PENETRATION 2017-2026

EXHIBIT 134 VIRTUAL VISITS MARKET IN BRAZIL 2021–2027 ($ BILLION)

EXHIBIT 135 NUMBER OF VIDEO CONSULTATION BY SPECIALTY 2021 (%)

EXHIBIT 136 VIRTUAL VISITS MARKET IN MEXICO 2021–2027 ($ BILLION)

EXHIBIT 137 VIRTUAL VISITS MARKET IN ARGENTINA 2021–2027 ($ BILLION)

EXHIBIT 138 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET– INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 139 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET – KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 140 VIRTUAL VISITS MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ BILLION)

EXHIBIT 141 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 142 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 143 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027

EXHIBIT 144 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 145 VIRTUAL VISITS MARKET IN TURKEY 2021–2027 ($ BILLION)

EXHIBIT 146 VIRTUAL VISITS MARKET IN UAE 2021–2027 ($ BILLION)

EXHIBIT 147 VIRTUAL VISITS MARKET IN SOUTH AFRICA 2021–2027 ($ BILLION)

EXHIBIT 148 PURE & DIVERSIFIED PLAYERS IN THE GLOBAL VIRTUAL VISITS MARKET

EXHIBIT 149 VENDORS OFFERING VIRTUAL VISITS: MARKET DOMINANCE ANALYSIS

EXHIBIT 150 VENDORS OFFERING VIRTUAL CARE VISITS: CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 151 AMERICAN WELL: REVENUE 2019-2021 ($ MILLION)

EXHIBIT 152 AMERICAN WELL: TOTAL R&D EXPENDITURE 2029-2021 ($ MILLION)

EXHIBIT 153 AMERICAN WELL: TOTAL PLATFORM SUBSCRIPTION REVENUE 2029-2021 ($ MILLION)

EXHIBIT 154 AMERICAN WELL: TOTAL VISITS REVENUE 2029-2021 ($ MILLION)

EXHIBIT 155 KONINKLIJKE PHILIPS: TOTAL REVENUE 2029-2021 ($ MILLION)

EXHIBIT 156 KONINKLIJKE PHILIPS: MARKET SHARE BY REPORTABLE SEGMENTS- 2021 ($ MILLION)

EXHIBIT 157 TELADOC HEALTH: TOTAL REVENUE 2019-2021 ($ MILLION)

EXHIBIT 158 TELADOC HEALTH: US TOTAL REVENUE 2019-2021 ($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 NUMBER OF CONNECTIVE SMART DEVICES OFFERED BY AMERICAN WELL

TABLE 4 NUMBER OF INTEGRATED SMART DEVICES OFFERED BY AMERICAN WELL

TABLE 5 CAPITAL RAISE BY THE COMPANIES IN THE FIELD OF VIRTUAL VISITS IN 2021

TABLE 6 NUMBER OF COMPANIES ENGAGED IN STRATEGIC ACQUISITIONS IN THE RECENT YEARS

TABLE 7 HOUSEHOLDS IN US WITH HOME INTERNET BY CONNECTION TYPE

TABLE 8 PERCENTAGE OF 933 MILLION TELEMEDICINE VISITS ACROSS SPECIALTIES 2018-2020

TABLE 9 AMD GLOBAL TELEMEDICINE: MAJOR PRODUCT OFFERINGS

TABLE 10 AMERICAN WELL: MAJOR PRODUCT OFFERINGS

TABLE 11 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS

TABLE 12 TELADOC HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 13 BANNER HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 14 BEATO: PRODUCT OFFERINGS

TABLE 15 BLUE SKY MD: MAJOR PRODUCT OFFERINGS

TABLE 16 CARECLIX: MAJOR PRODUCT OFFERINGS

TABLE 17 CERNER: MAJOR PRODUCT OFFERINGS

TABLE 18 CHI HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 19 CHIRON HEALTH: PRODUCT OFFERINGS

TABLE 20 CVS HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 21 DIALOGUE: PRODUCT OFFERINGS

TABLE 22 DOCTOR ON DEMAND: MAJOR PRODUCT OFFERINGS

TABLE 23 DOXY.ME: MAJOR PRODUCT OFFERINGS

TABLE 24 EAGLE TELEMEDICINE: MAJOR PRODUCT OFFERINGS

TABLE 25 EDGEMED HEALTHCARE: PRODUCT OFFERINGS

TABLE 26 EVISIT: MAJOR PRODUCT OFFERINGS

TABLE 27 HEALTHTAP: MAJOR PRODUCT OFFERINGS

TABLE 28 HEALTH AT HAND: PRODUCT OFFERINGS

TABLE 29 HEALTHHERO: PRODUCT OFFERINGS

TABLE 30 INSTAPRACT: PRODUCT OFFERINGS

TABLE 31 MDLIVE: MAJOR PRODUCT OFFERINGS

TABLE 32 MEDIBUDDY: PRODUCT OFFERINGS

TABLE 33 MFINE: PRODUCT OFFERINGS

TABLE 34 NEUROSYNAPTIC COMMUNICATIONS: PRODUCT OFFERINGS

TABLE 35 NEXTCARE: MAJOR PRODUCT OFFERINGS

TABLE 36 OPTUM: MAJOR PRODUCT OFFERINGS

TABLE 37 PLUSHCARE: PRODUCT OFFERINGS

TABLE 38 PIEDMONT HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 39 PRACTO: MAJOR SERVICE OFFERINGS

TABLE 40 RO: PRODUCT OFFERINGS

TABLE 41 RECURO HEALTH: PRODUCT OFFERINGS

TABLE 42 STEADYMD: MAJOR PRODUCT OFFERINGS

TABLE 43 SOC TELEMED: MAJOR PRODUCT OFFERINGS

TABLE 44 TRUDOC HEALTH CARE: PRODUCT OFFERINGS

TABLE 45 VIDYO: MAJOR PRODUCT OFFERINGS

TABLE 46 VSEE: PRODUCT OFFERINGS

TABLE 47 WALMART HEALTH VIRTUAL CARE: MAJOR PRODUCT OFFERINGS

TABLE 48 ZIPNOSIS: MAJOR PRODUCT OFFERINGS

TABLE 49 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)

TABLE 50 GLOBAL VIRTUAL VISITS MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 51 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 52 GLOBAL VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)

TABLE 53 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 54 GLOBAL VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)

TABLE 55 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)

TABLE 56 GLOBAL VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)

TABLE 57 NORTH AMERICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 58 NORTH AMERICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)

TABLE 59 NORTH AMERICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 60 NORTH AMERICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)

TABLE 61 NORTH AMERICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)

TABLE 62 NORTH AMERICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)

TABLE 63 EUROPE VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 64 EUROPE VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)

TABLE 65 EUROPE VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 66 EUROPE VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)

TABLE 67 EUROPE VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)

TABLE 68 EUROPE VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)

TABLE 69 APAC VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 70 APAC VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)

TABLE 71 APAC VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 72 APAC VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)

TABLE 73 APAC VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)

TABLE 74 APAC VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)

TABLE 75 LATIN AMERICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 76 LATIN AMERICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)

TABLE 77 LATIN AMERICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 78 LATIN AMERICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)

TABLE 79 LATIN AMERICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)

TABLE 80 LATIN AMERICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)

TABLE 81 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 82 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY COMPONENT 2021−2027 (%)

TABLE 83 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 84 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY APPLICATION 2021−2027 (%)

TABLE 85 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)

TABLE 86 MIDDLE EAST & AFRICA VIRTUAL VISITS MARKET BY PATIENT GROUP 2021−2027 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY COMPONENT

4.3.2 MARKET SEGMENTATION BY APPLICATION

4.3.3 MARKET SEGMENTATION BY PATIENT GROUP

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

 

8 PREMIUM INSIGHTS

8.1 OVERVIEW

8.1.1 VENDOR ACTIVITIES IN THE MARKET

8.1.2 FACTORS CONTRIBUTING TO MARKET GROWTH

8.1.3 IMPACT OF COVID-19 PANDEMIC

8.1.4 MARKET ANALYSIS BY SEGMENTATION

9 MARKET OPPORTUNITIES & TRENDS

9.1 EMERGING SMART INTEGRATED DEVICES

9.2 INCREASING GROWTH OF VIRTUAL VISITS ACTIVITIES

9.3 INCREASING STRATEGIC PARTNERSHIPS & MERGERS/ACQUISITIONS

 

10 MARKET GROWTH ENABLERS

10.1 HIGHER REIMBURSEMENTS BY INSURERS AND GOVERNMENTS FOR VIRTUAL VISITS

10.2 LARGER TARGET POOL OF PATIENTS REQUIRING VIRTUAL VISITS

10.3 RISE OF VIRTUAL HOSPITALS

 

11 MARKET RESTRAINTS

11.1 LACK OF ACCESS TO FIXED INTERNET SERVICE

11.2 LEGAL BARRIERS & LACK OF STANDARD REGULATIONS FOR VIRTUAL VISITS

11.3 DATA SECURITY AND PRIVACY RISKS

 

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 COMPONENT

12.2.2 APPLICATION

12.2.3 PATIENT GROUP

12.2.4 GEOGRAPHY

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

 

13 COMPONENT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 SERVICE

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 HARDWARE & SOFTWARE

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

 

14 APPLICATION

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 GENERAL CONSULTATION

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 BEHAVIORAL HEALTH

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 CHRONIC CARE MANAGEMENT

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

14.6 URGENT CARE

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.6.3 MARKET BY GEOGRAPHY

14.7 OTHERS

14.7.1 MARKET OVERVIEW

14.7.2 MARKET SIZE & FORECAST

14.7.3 MARKET BY GEOGRAPHY

 

15 PATIENT GROUP

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 ADULTS

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 PEDIATRIC

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

 

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 GEOGRAPHIC OVERVIEW

 

17 NORTH AMERICA

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 NORTH AMERICA: COMPONENT

17.4 NORTH AMERICA: APPLICATION

17.5 NORTH AMERICA: PATIENT GROUP

17.6 KEY COUNTRIES

17.6.1 US: MARKET SIZE & FORECAST

17.6.2 CANADA: MARKET SIZE & FORECAST

 

18 EUROPE

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 EUROPE: COMPONENT

18.4 EUROPE: APPLICATION

18.5 EUROPE: PATIENT GROUP

18.6 KEY COUNTRIES

18.6.1 UK: MARKET SIZE & FORECAST

18.6.2 FRANCE: MARKET SIZE & FORECAST

18.6.3 GERMANY: MARKET SIZE & FORECAST

18.6.4 ITALY: MARKET SIZE & FORECAST

18.6.5 SPAIN: MARKET SIZE & FORECAST

 

19 APAC

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 APAC: COMPONENT

19.4 APAC: APPLICATION

19.5 APAC: PATIENT GROUP

19.6 KEY COUNTRIES

19.6.1 JAPAN: MARKET SIZE & FORECAST

19.6.2 CHINA: MARKET SIZE & FORECAST

19.6.3 AUSTRALIA: MARKET SIZE & FORECAST

19.6.4 SOUTH KOREA: MARKET SIZE & FORECAST

19.6.5 INDIA: MARKET SIZE & FORECAST

 

20 LATIN AMERICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 LATIN AMERICA: COMPONENT

20.4 LATIN AMERICA: APPLICATION

20.5 LATIN AMERICA: PATIENT GROUP

20.6 KEY COUNTRIES

20.6.1 BRAZIL: MARKET SIZE & FORECAST

20.6.2 MEXICO: MARKET SIZE & FORECAST

20.6.3 ARGENTINA: MARKET SIZE & FORECAST

 

21 MIDDLE EAST & AFRICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 MIDDLE EAST & AFRICA: COMPONENT

21.4 MIDDLE EAST & AFRICA: APPLICATION

21.5 MIDDLE EAST & AFRICA: PATIENT GROUP

21.6 KEY COUNTRIES

21.6.1 TURKEY: MARKET SIZE & FORECAST

21.6.2 UAE: MARKET SIZE & FORECAST

21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST

 

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW

22.2 MARKET SHARE ANALYSIS

22.2.1 AMD GLOBAL TELEMEDICINE

22.2.2 AMERICAN WELL

22.2.3 KONINKLIJKE PHILIPS

22.2.4 TELADOC HEALTH

 

23 KEY COMPANY PROFILES

23.1 AMD GLOBAL TELEMEDICINE

23.1.1 BUSINESS OVERVIEW

23.1.1 PRODUCT OFFERINGS

23.1.2 KEY STRATEGIES

23.1.3 KEY STRENGTHS

23.1.4 KEY OPPORTUNITIES

23.2 AMERICAN WELL

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERINGS

23.2.3 KEY STRATEGIES

23.2.4 KEY STRENGTHS

23.2.5 KEY OPPORTUNITIES

23.3 KONINKLIJKE PHILIPS

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERINGS

23.3.3 KEY STRATEGIES

23.3.4 KEY STRENGTHS

23.3.5 KEY OPPORTUNITIES

23.4 TELADOC HEALTH

23.4.1 BUSINESS OVERVIEW

23.4.2 PRODUCT OFFERINGS

23.4.3 KEY STRATEGIES

23.4.4 KEY STRENGTHS

23.4.5 KEY OPPORTUNITIES

 

24 OTHER PROMINENT VENDORS

24.1 BANNER HEALTH

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.2 BEATO

24.2.1 BUSINESS OVERVIEW

24.2.2 PRODUCT OFFERINGS

24.3 BLUE SKY MD

24.3.1 BUSINESS OVERVIEW

24.3.2 PRODUCT OFFERINGS

24.4 CARECLIX

24.4.1 BUSINESS OVERVIEW

24.4.2 PRODUCT OFFERINGS

24.5 CERNER

24.5.1 BUSINESS OVERVIEW

24.5.2 SERVICE OFFERINGS

24.6 CHI HEALTH

24.6.1 BUSINESS OVERVIEW

24.6.2 PRODUCT OFFERINGS

24.7 CHIRON HEALTH

24.7.1 BUSINESS OVERVIEW

24.7.2 PRODUCT OFFERINGS

24.8 CVS HEALTH

24.8.1 BUSINESS OVERVIEW

24.8.2 PRODUCT OFFERINGS

24.9 DIALOGUE

24.9.1 BUSINESS OVERVIEW

24.9.2 PRODUCT OFFERINGS

24.10 DOCTOR ON DEMAND

24.10.1 BUSINESS OVERVIEW

24.10.2 PRODUCT OFFERINGS

24.11 DOXY.ME

24.11.1 BUSINESS OVERVIEW

24.11.2 PRODUCT OFFERINGS

24.12 EAGLE TELEMEDICINE

24.12.1 BUSINESS OVERVIEW

24.12.2 PRODUCT OFFERINGS

24.13 EDGEMED HEALTHCARE

24.13.1 BUSINESS OVERVIEW

24.13.2 PRODUCT OFFERINGS

24.14 EVISIT

24.14.1 BUSINESS OVERVIEW

24.14.2 PRODUCT OFFERINGS

24.15 HEALTHTAP

24.15.1 BUSINESS OVERVIEW

24.15.2 PRODUCT OFFERINGS

24.16 HEALTH AT HAND

24.16.1 BUSINESS OVERVIEW

24.16.2 PRODUCT OFFERINGS

24.17 HEALTHHERO

24.17.1 BUSINESS OVERVIEW

24.17.2 PRODUCT OFFERINGS

24.18 INSTAPRACT

24.18.1 BUSINESS OVERVIEW

24.18.2 PRODUCT OFFERINGS

24.19 MDLIVE

24.19.1 BUSINESS OVERVIEW

24.19.2 PRODUCT OFFERINGS

24.20 MEDIBUDDY

24.20.1 BUSINESS OVERVIEW

24.20.2 PRODUCT OFFERINGS

24.21 MFINE

24.21.1 BUSINESS OVERVIEW

24.21.2 PRODUCT OFFERINGS

24.22 NEUROSYNAPTIC COMMUNICATIONS

24.22.1 BUSINESS OVERVIEW

24.22.2 PRODUCT OFFERINGS

24.23 NEXTCARE

24.23.1 BUSINESS OVERVIEW

24.23.2 PRODUCT OFFERINGS

24.24 OPTUM

24.24.1 BUSINESS OVERVIEW

24.24.2 PRODUCT OFFERINGS

24.25 PLUSHCARE

24.25.1 BUSINESS OVERVIEW

24.25.2 PRODUCT OFFERINGS

24.26 PIEDMONT HEALTHCARE

24.26.1 BUSINESS OVERVIEW

24.26.2 PRODUCT OFFERINGS

24.27 PRACTO

24.27.1 BUSINESS OVERVIEW

24.27.2 PRODUCT OFFERINGS

24.28 RO

24.28.1 BUSINESS OVERVIEW

24.28.2 PRODUCT OFFERINGS

24.29 REECURO HEALTH

24.29.1 BUSINESS OVERVIEW

24.29.2 PRODUCT OFFERINGS

24.30 STEADYMD

24.30.1 BUSINESS OVERVIEW

24.30.2 PRODUCT OFFERINGS

24.31 SOC TELEMED

24.31.1 BUSINESS OVERVIEW

24.31.2 PRODUCT OFFERINGS

24.32 TRUDOC HEALTH CARE

24.32.1 BUSINESS OVERVIEW

24.32.2 PRODUCT OFFERINGS

24.33 VIDYO

24.33.1 BUSINESS OVERVIEW

24.33.2 PRODUCT OFFERINGS

24.34 VSEE

24.34.1 BUSINESS OVERVIEW

24.34.2 PRODUCT OFFERINGS

24.35 WALMART HEALTH VIRTUAL CARE

24.35.1 BUSINESS OVERVIEW

24.35.2 PRODUCT OFFERINGS

24.36 ZIPNOSIS

24.36.1 BUSINESS OVERVIEW

24.36.2 PRODUCT OFFERINGS

 

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS

25.2 STRATEGIC RECOMMENDATIONS

 

26 QUANTITATIVE SUMMARY

26.1 MARKET BY GEOGRAPHY

26.2 MARKET BY COMPONENT

26.3 MARKET BY APPLICATION

26.4 MARKET BY PATIENT GROUP

26.5 NORTH AMERICA BY COMPONENT

26.6 NORTH AMERICA BY APPLICATION

26.7 NORTH AMERICA BY PATIENT GROUP

26.8 EUROPE BY COMPONENT

26.9 EUROPE BY APPLICATION

26.10 EUROPE BY PATIENT GROUP

26.11 APAC BY COMPONENT

26.12 APAC BY APPLICATION

26.13 APAC BY PATIENT GROUP

26.14 LATIN AMERICA BY COMPONENT

26.15 LATIN AMERICA BY APPLICATION

26.16 LATIN AMERICA BY PATIENT GROUP

26.17 MIDDLE EAST & AFRICA BY COMPONENT

26.18 MIDDLE EAST & AFRICA BY APPLICATION

26.19 MIDDLE EAST & AFRICA BY PATIENT GROUP

27 APPENDIX

27.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the global Virtual Visits market?

The global virtual visits market size was valued at $13.26 billion in 2021 and is expected to reach $56.02 billion by 2027, growing at a CAGR of 27.15%.

What is the growth rate of the global virtual visits market?

The global virtual visits market is growing at a CAGR of 27.15% from 2022 to 2027.

Who are the leading players in the global virtual visits market?

The key players in the market are AMD Global Telemedicine, American Well, Koninklijke Philips, and Teladoc Health

Which region has the highest number of virtual visits service providers?

North America dominates the virtual care market with the presence of critical vendors.

What is the growth rate of the hardware and software segment of the global virtual visits market?

The hardware and software segment is expected to grow at an excellent pace in the forecast period, with a CAGR of 26.20%.